We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Erytech

News List

ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients firstwordpharma
July 22, 2021
ERYTECH today announced its intention to move forward towards the submission of a BLA to the US Food and Drug Administration for eryaspase in hypersensitive acute lymphoblastic leukemia patients following feedback from the agency in a pre-BLA meeting.
Erytech and Queen’s University collaborate for arginase-1 deficiency treatment pharmaceutical-technology
July 14, 2017
French biopharmaceutical company Erytech Pharma has entered a research collaboration with Queen’s University in Canada to advance the preclinical development of its eryminase programme, particularly for the treatment of arginase-1 deficiency.